Fortis Healthcare Limited has announced a significant operational move by signing an Operations and Maintenance (O&M) agreement for Gleneagles BGS Hospital in Karnataka. The healthcare giant confirmed that the agreement is set to take effect on October 1, 2025, marking a new chapter in its operational expansion.

Agreement Details

The company disclosed the information through a regulatory filing to the National Stock Exchange of India Ltd. and BSE Limited on October 1, 2025. According to the filing, Fortis Healthcare and Gleneagles Healthcare India Private Limited have mutually agreed that the O&M Agreement will become effective from October 1, 2025, specifically for the Gleneagles BGS Hospital in Karnataka.

Regulatory Compliance

The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015. Fortis Healthcare's Company Secretary and Compliance Officer, Satyendra Chauhan, signed off on the regulatory filing, ensuring transparency and adherence to market regulations.

Prior Developments

This agreement follows an earlier intimation by Fortis Healthcare on July 23, 2025, regarding operation and maintenance services with Gleneagles Healthcare India Private Limited. The latest announcement confirms the finalization of the agreement and its effective date.

Conditions Precedent

The company stated that the agreement's effectiveness was subject to receiving necessary acceptances or No Objection Certificates (NOCs) from relevant third parties. These conditions have been met, paving the way for the agreement to come into force as planned.

Implications for Fortis Healthcare

This O&M agreement represents a strategic move for Fortis Healthcare, potentially expanding its operational footprint in Karnataka. By taking on the operations and maintenance of Gleneagles BGS Hospital, Fortis is likely aiming to strengthen its presence in the region and enhance its service offerings.

The healthcare sector continues to evolve, and such operational agreements between major players could signal a trend towards more collaborative and efficient healthcare management models. As this agreement takes effect in October 2025, stakeholders will be keen to observe its impact on Fortis Healthcare's operational metrics and overall performance in the coming years.

Fortis Healthcare Limited has announced significant changes to its Board of Directors, effective September 09, 2025. The company has appointed Dr. Keith Hsiu Chin Lim as an Additional Director while bidding farewell to Tomo Nagahiro.

New Appointment

Dr. Keith Hsiu Chin Lim has been appointed as an Additional Director (Non-Executive & Non-Independent) of Fortis Healthcare. The appointment, based on the recommendation of the Nomination and Remuneration Committee, took effect from the close of business hours on September 09, 2025.

Director Resignation

Simultaneously, Tomo Nagahiro has stepped down from his position as Non-Executive & Non-Independent Director due to other commitments and responsibilities. His resignation is also effective from the close of business hours on September 09, 2025.

About Dr. Keith Hsiu Chin Lim

Dr. Lim brings a wealth of experience to Fortis Healthcare:

• Currently serves as Group Chief Medical Officer at IHH Healthcare
• Over 20 years of experience as a radiation oncologist
• Previously held positions at National University Health System (NUHS) and Singapore's Ministry of Health
• Recipient of Singapore's National Medical Excellence Award
• Holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) from the National University of Singapore
• Fellow of the Royal Australian and New Zealand College of Radiologists

In his role at IHH Healthcare, Dr. Lim oversees clinical quality, patient safety, and value-based care across the group. His expertise includes setting policies and driving quality improvements to ensure world-class and cost-effective patient care.

Board Relationships

While Dr. Lim is not related to any of the company's directors, it's worth noting that he, along with Dr. Prem Kumar Nair, Mr. Dilip Kadambi, Mr. Ashok Pandit, and Mr. Lim Tsin Lin, serves as a nominee director of Northern TK Venture Pte. Ltd.

The board changes reflect Fortis Healthcare's ongoing commitment to maintaining strong leadership and expertise in the healthcare sector. As the company continues to evolve, these strategic appointments aim to further strengthen its position in the industry.